VBI Vaccines Inc. VBIV

Full chart Compare
Set alert

Price alert · VBIV

All alert types
0.07 USD 0.00 (+0.00%)

At closeAug 7, 2024, 4:00 PM EDT

0.0574 Day range 0.0866
0.0574 52-week range 1.35

Revenue & Expenses

Revenue by
Net Loss → Expenses: $92.84MExpenses → Gross Loss: $5.82MExpenses → Selling, General & Admin: $40.15MExpenses → Research & Development: $9.34MExpenses → Interest Expense: $8.06MExpenses → Other Expenses: $29.46MChina Hong Kong → Revenue: $5.58MUnited States → Revenue: $1.84MRevenue → Cost of Revenue: $8.68MEurope → Revenue: $1.08MIsrael → Revenue: $167.00KNet Loss$92.84MCost of Revenue$14.50MExpenses$92.84MGross Loss$5.82MSelling, General & Admin$40.15MResearch & Development$9.34MInterest Expense$8.06MOther Expenses$29.46MRevenue$8.68MChina Hong Kong$5.58MUnited States$1.84MEurope$1.08MIsrael$167.00K

Latest period ending Dec 31, 2023 · select a line to chart its full history

Annual income statement

VBIV annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
8.68M1.08M631.00K1.06M2.22M
8.68M1.08M631.00K1.06M2.22M
12.51M11.28M10.77M9.17M7.90M
-3.83M-10.19M-10.14M-8.11M-5.68M
76.09M71.63M57.89M35.51M46.72M
9.34M15.51M19.56M14.86M26.33M
42.14M56.12M38.34M20.65M14.09M
-79.91M-81.82M-68.03M-43.62M-52.40M
6.40M4.01M4.73M2.71M2.20M
-92.84M-113.30M-69.75M-46.23M-54.81M
-93.84M-113.30M-69.75M-46.23M-54.81M
-93.84M-113.30M-69.75M-46.23M-54.81M
-92.84M-113.30M-69.75M-46.23M-54.81M
-6.03-13.16-8.10-6.30-13.80
-6.03-13.16-8.10-6.30-13.80
-6.03-13.16-8.10-6.30-13.80
-86.44M-109.30M-65.02M-43.52M-52.62M
-86.44M-109.30M-65.02M-43.52M-52.62M
1.00M0000
15.57M8.61M8.50M7.28M3.98M
15.57M8.61M8.50M7.28M3.98M